NCT06737107 Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer
| NCT ID | NCT06737107 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Scientific Institute San Raffaele |
| Condition | Early Stage Lung Cancer (I and II) |
| Study Type | OBSERVATIONAL |
| Enrollment | 472 participants |
| Start Date | 2024-11-26 |
| Primary Completion | 2025-12-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 472 participants in total. It began in 2024-11-26 with a primary completion date of 2025-12-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is a retrospective, observational and multicentric study. The study describes robotic segmentectomies performed in four referred centers, with the aim to assess the perioperative compilications of robotic segmentectomies compared to video-assisted thoracoscopic surgery (VATS) and open approach.
Eligibility Criteria
Inclusion Criteria: * Pre or post-operative diagnosis of NSCLC surgically treated with pulmonary segmentectomy from 1st January 2010 to the 31st to December 2023. * Age \> then 18 years at the moment of surgery Exclusion Criteria: * Age \< then 18 years at the moment of surgery * diagnosis other than NSCLC
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06737107 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Early Stage Lung Cancer (I and II). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06737107 currently recruiting?
Yes, NCT06737107 is actively recruiting participants. Contact the research team at novellis.pierluigi@hsr.it for enrollment information.
Where is the NCT06737107 trial being conducted?
This trial is being conducted at Rozzano, Italy, Milan, Italy, Milan, Italy, Rome, Italy.
Who is sponsoring the NCT06737107 clinical trial?
NCT06737107 is sponsored by Scientific Institute San Raffaele. The trial plans to enroll 472 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.